RUCAPARIB for Malignant peritoneal neoplasm: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 7 adverse event reports in the FDA FAERS database where RUCAPARIB was used for Malignant peritoneal neoplasm.
Most Reported Side Effects for RUCAPARIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Anaemia | 49 | 11.3% | 2 | 37 |
| Acute kidney injury | 34 | 7.8% | 6 | 34 |
| Febrile neutropenia | 33 | 7.6% | 2 | 33 |
| Fatigue | 32 | 7.4% | 1 | 10 |
| Nausea | 30 | 6.9% | 0 | 15 |
| Pancytopenia | 27 | 6.2% | 2 | 24 |
| Diarrhoea | 23 | 5.3% | 1 | 18 |
| Drug ineffective | 22 | 5.1% | 6 | 1 |
| Vomiting | 20 | 4.6% | 0 | 16 |
| Abdominal pain | 17 | 3.9% | 0 | 15 |
| Thrombocytopenia | 17 | 3.9% | 4 | 12 |
| Constipation | 15 | 3.5% | 0 | 5 |
| Malignant neoplasm progression | 15 | 3.5% | 8 | 6 |
| Pyrexia | 13 | 3.0% | 0 | 11 |
| Decreased appetite | 12 | 2.8% | 0 | 3 |
Other Indications for RUCAPARIB
Ovarian cancer (201)
Prostate cancer metastatic (34)
Small cell lung cancer (29)
Hormone-refractory prostate cancer (27)
Prostate cancer (27)
Endometrial cancer (15)
Neoplasm (13)
Product used for unknown indication (12)
Fallopian tube cancer (9)
Neoplasm malignant (9)
Other Drugs Used for Malignant peritoneal neoplasm
NIRAPARIB (1,632)
CARBOPLATIN (361)
BEVACIZUMAB (340)
RUCAPARIB CAMSYLATE (332)
PACLITAXEL (274)
OLAPARIB (190)
DOXORUBICIN (97)
ATEZOLIZUMAB (67)
DOCETAXEL (49)
OXALIPLATIN (46)